A comprehensive review of highly pathogenic avian influenza (HPAI) H5N1: An imminent threat at doorstep.

[1]  Yuying Liang.  Pathogenicity and virulence of influenza , 2023, Virulence.

[2]  G. Gao,et al.  Novel Avian Influenza Virus (H5N1) Clade 2.3.4.4b Reassortants in Migratory Birds, China , 2023, Emerging infectious diseases.

[3]  Alonzo Alfaro-Núñez,et al.  Phylogenetic analysis reveals that the H5N1 avian influenza A outbreak in poultry in Ecuador in November 2022 is associated to the highly pathogenic clade 2.3.4.4b. , 2023, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  Julianna B. Lenoch,et al.  Highly Pathogenic Avian Influenza A(H5N1) Virus Outbreak in New England Seals, United States , 2023, Emerging infectious diseases.

[5]  T. Mettenleiter,et al.  Zoonotic Animal Influenza Virus and Potential Mixing Vessel Hosts , 2023, Viruses.

[6]  T. Kuiken,et al.  The pathogenesis of zoonotic viral infections: Lessons learned by studying reservoir hosts , 2023, Frontiers in Microbiology.

[7]  M. Wajid,et al.  Highly pathogenic avian influenza (HPAI A H5N1) outbreak in Spain: its mitigation through the One Health approach – a short communication , 2023, Annals of Medicine and Surgery.

[8]  S. Schultz-Cherry,et al.  We need to keep an eye on avian influenza , 2023, Nature Reviews Immunology.

[9]  S. Reid,et al.  The Role of Airborne Particles in the Epidemiology of Clade 2.3.4.4b H5N1 High Pathogenicity Avian Influenza Virus in Commercial Poultry Production Units , 2023, bioRxiv.

[10]  T. Kuiken,et al.  Evolution of highly pathogenic H5N1 influenza A virus in the central nervous system of ferrets , 2023, PLoS pathogens.

[11]  S. Bhadada,et al.  Immune Control of Avian Influenza Virus Infection and Its Vaccine Development , 2023, Vaccines.

[12]  N. Roberts,et al.  The Enigma of Lymphocyte Apoptosis in the Response to Influenza Virus Infection , 2023, Viruses.

[13]  T. Park,et al.  Highly sensitive and label-free detection of influenza H5N1 viral proteins using affinity peptide and porous BSA/MXene nanocomposite electrode. , 2023, Analytica chimica acta.

[14]  S. Finke,et al.  Phenotypic effects of mutations observed in the neuraminidase of human origin H5N1 influenza A viruses , 2023, PLoS pathogens.

[15]  F. Pozo,et al.  Influenza A(H5N1) detection in two asymptomatic poultry farm workers in Spain, September to October 2022: suspected environmental contamination , 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  Hailiang Sun,et al.  Overexpression of TRIM16 Reduces the Titer of H5N1 Highly Pathogenic Avian Influenza Virus and Promotes the Expression of Antioxidant Genes through Regulating the SQSTM1-NRF2-KEAP1 Axis , 2023, Viruses.

[17]  Min-Suk Song,et al.  Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy , 2023, Microorganisms.

[18]  Hualan Chen,et al.  Alarming situation of emerging H5 and H7 avian influenza and effective control strategies , 2022, Emerging microbes & infections.

[19]  P. Puthavathana,et al.  Genetic evolution of hemagglutinin and neuraminidase genes of H5N1 highly pathogenic avian influenza viruses in Thailand , 2022, PeerJ.

[20]  M. Venkataramana,et al.  Respiratory illness virus infections with special emphasis on COVID-19 , 2022, European Journal of Medical Research.

[21]  Gaiping Zhang,et al.  Characterization of Neutralizing Monoclonal Antibodies and Identification of a Novel Conserved C-Terminal Linear Epitope on the Hemagglutinin Protein of the H9N2 Avian Influenza Virus , 2022, Viruses.

[22]  N. Feng,et al.  Taurolidine improved protection against highly pathogenetic avian influenza H5N1 virus lethal-infection in mouse model by regulating the NF-κB signaling pathway , 2022, Virologica Sinica.

[23]  Hualan Chen,et al.  H1N1 Influenza A Virus Protein NS2 Inhibits Innate Immune Response by Targeting IRF7 , 2022, Viruses.

[24]  C. Terregino,et al.  Silent Infection of Highly Pathogenic Avian Influenza Virus (H5N1) Clade 2.3.4.4b in a Commercial Chicken Broiler Flock in Italy , 2022, Viruses.

[25]  K. Okuya,et al.  Genetically Diverse Highly Pathogenic Avian Influenza A(H5N1/H5N8) Viruses among Wild Waterfowl and Domestic Poultry, Japan, 2021 , 2022, Emerging infectious diseases.

[26]  M. Javed,et al.  Comprehensive computational analysis reveals H5N1 influenza virus-encoded miRNAs and host-specific targets associated with antiviral immune responses and protein binding , 2022, PloS one.

[27]  T. Kawai,et al.  Antigen Presentation in the Lung , 2022, Frontiers in Immunology.

[28]  Ravendra P. Chauhan,et al.  An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updates , 2022, Virus Genes.

[29]  H. Kumalo,et al.  Molecular Dynamic Investigation of H5N1 Influenza Virus Dual H274Y-I222K Mutation Resistance to Peramivir , 2022, bioRxiv.

[30]  P. Österlund,et al.  Inactivation efficacy of H5N1 avian influenza virus by commonly used sample preparation reagents for safe laboratory practices. , 2022, Journal of virological methods.

[31]  T. Kuiken,et al.  Avian influenza overview September – December 2021 , 2021, EFSA journal. European Food Safety Authority.

[32]  Y. Sakoda,et al.  Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection , 2021, Viruses.

[33]  F. Harders,et al.  Highly Pathogenic Avian Influenza A(H5N1) Virus in Wild Red Foxes, the Netherlands, 2021 , 2021, Emerging Infectious Diseases.

[34]  A. Komissarov,et al.  Highly Pathogenic Avian Influenza A(H5N8) Virus Clade 2.3.4.4b, Western Siberia, Russia, 2020 , 2021, Emerging infectious diseases.

[35]  Xiaoquan Wang,et al.  NS1: A Key Protein in the “Game” Between Influenza A Virus and Host in Innate Immunity , 2021, Frontiers in Cellular and Infection Microbiology.

[36]  G. Gao,et al.  Emerging H5N8 avian influenza viruses , 2021, Science.

[37]  J. Kubicek-Sutherland,et al.  Nucleic Acid-Based Sensing Techniques for Diagnostics and Surveillance of Influenza , 2021, Biosensors.

[38]  R. Fouchier,et al.  Highly Pathogenic Avian Influenza Viruses at the Wild–Domestic Bird Interface in Europe: Future Directions for Research and Surveillance , 2021, Viruses.

[39]  D. Fremont,et al.  Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination , 2021, Cell reports.

[40]  J. Grimes,et al.  Structural insights into RNA polymerases of negative-sense RNA viruses , 2021, Nature Reviews Microbiology.

[41]  W. Guan,et al.  Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study , 2021, Emerging microbes & infections.

[42]  K. Olival,et al.  Detection of influenza virus in rectal swabs of patients admitted in hospital for febrile illnesses in Thailand , 2021, SAGE open medicine.

[43]  A. Thompson,et al.  Adaptation of influenza viruses to human airway receptors , 2020, The Journal of biological chemistry.

[44]  James C. Kile,et al.  Association of Biosecurity and Hygiene Practices with Environmental Contamination with Influenza A Viruses in Live Bird Markets, Bangladesh , 2020, Emerging infectious diseases.

[45]  M. Beer,et al.  Genesis and spread of multiple reassortants during the 2016/2017 H5 avian influenza epidemic in Eurasia , 2020, Proceedings of the National Academy of Sciences.

[46]  K. Legge,et al.  Influenza A Virus Vaccination: Immunity, Protection, and Recent Advances Toward A Universal Vaccine , 2020, Vaccines.

[47]  R. Webby,et al.  Monoclonal Antibody Therapy Protects Pharmacologically Immunosuppressed Mice from Lethal Infection with Influenza B Virus , 2020, Antimicrobial Agents and Chemotherapy.

[48]  I. Barr,et al.  Diversity of A(H5N1) clade 2.3.2.1c avian influenza viruses with evidence of reassortment in Cambodia, 2014-2016 , 2019, PloS one.

[49]  A. Amonsin,et al.  Co-circulation and characterization of HPAI-H5N1 and LPAI-H9N2 recovered from a duck farm, Yogyakarta, Indonesia. , 2019, Transboundary and emerging diseases.

[50]  G. Rimmelzwaan,et al.  Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. , 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[51]  M. Tokeshi,et al.  Rapid, Sensitive, and Selective Detection of H5 Hemagglutinin from Avian Influenza Virus Using an Immunowall Device , 2019, ACS omega.

[52]  B. Flannery,et al.  Comparison of Respiratory Specimen Collection Methods for Detection of Influenza Virus Infection by Reverse Transcription-PCR: a Literature Review , 2019, Journal of Clinical Microbiology.

[53]  T. Uyeki,et al.  Influenza virus-related critical illness: prevention, diagnosis, treatment , 2019, Critical Care.

[54]  Sachin S Keng,et al.  A novel I117T substitution in neuraminidase of highly pathogenic avian influenza H5N1 virus conferring reduced susceptibility to oseltamivir and zanamivir. , 2019, Veterinary microbiology.

[55]  H. van Bakel,et al.  A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses , 2019, Nature Microbiology.

[56]  D. Eggink,et al.  Viral Factors Associated With the High Mortality Related to Human Infections With Clade 2.1 Influenza A/H5N1 Virus in Indonesia , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[57]  J. Yewdell,et al.  Influenza Hemagglutinin and Neuraminidase: Yin–Yang Proteins Coevolving to Thwart Immunity , 2019, Viruses.

[58]  N. N. Tran Minh,et al.  Fatal avian influenza A(H5N1) infection in a 36‐week pregnant woman survived by her newborn in Sóc Trăng Province, Vietnam, 2012 , 2019, Influenza and other respiratory viruses.

[59]  A. Glatman-Freedman,et al.  A method to identify respiratory virus infections in clinical samples using next-generation sequencing , 2019, Scientific Reports.

[60]  L. Brown,et al.  Influenza Virus Neuraminidase Structure and Functions , 2019, Front. Microbiol..

[61]  K. Subbarao,et al.  Immune Responses to Avian Influenza Viruses , 2019, The Journal of Immunology.

[62]  K. Ungchusak,et al.  Complete Genomic Sequences of Highly Pathogenic H5N1 Avian Influenza Viruses Obtained Directly from Human Autopsy Specimens , 2018, Microbiology Resource Announcements.

[63]  A. Monto,et al.  Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans , 2018, Journal of Virology.

[64]  Karolina Dziąbowska,et al.  Detection Methods of Human and Animal Influenza Virus—Current Trends , 2018, Biosensors.

[65]  M. Killian,et al.  Transmission Dynamics of Highly Pathogenic Avian Influenza Virus A(H5Nx) Clade 2.3.4.4, North America, 2014–2015 , 2018, Emerging infectious diseases.

[66]  F. Hayden,et al.  Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents , 2018, The New England journal of medicine.

[67]  T. Sutton.  The Pandemic Threat of Emerging H5 and H7 Avian Influenza Viruses , 2018, Viruses.

[68]  A. L'Huillier,et al.  Zoonotic Influenza and Human Health—Part 2: Clinical Features, Diagnosis, Treatment, and Prevention Strategies , 2018, Current Infectious Disease Reports.

[69]  K. Richards,et al.  CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential , 2018, Immunological reviews.

[70]  L. Delang,et al.  Favipiravir as a potential countermeasure against neglected and emerging RNA viruses , 2018, Antiviral research.

[71]  Jin Hyang Kim,et al.  Extensive T cell cross-reactivity between diverse seasonal influenza strains in the ferret model , 2018, Scientific Reports.

[72]  C. Berry.  Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies? , 2018, Human vaccines & immunotherapeutics.

[73]  T. Ross,et al.  Towards a universal influenza vaccine: different approaches for one goal , 2018, Virology Journal.

[74]  G. Neumann,et al.  Mutations in the PA Protein of Avian H5N1 Influenza Viruses Affect Polymerase Activity and Mouse Virulence , 2017, Journal of Virology.

[75]  F. Rezaei,et al.  The Comparison of Sensitivity and Specificity of ELISA-based Microneutralization Test with Hemagglutination Inhibition Test to Evaluate Neutralizing Antibody against Influenza Virus (H1N1) , 2017, Iranian journal of public health.

[76]  F. Hayden,et al.  The hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection , 2017, Influenza and other respiratory viruses.

[77]  Song-Liang Wang,et al.  Evolution of Influenza A Virus by Mutation and Re-Assortment , 2017, International journal of molecular sciences.

[78]  J. Wrammert,et al.  Novel multiplex assay platforms to detect influenza A hemagglutinin subtype‐specific antibody responses for high‐throughput and in‐field applications , 2017, Influenza and other respiratory viruses.

[79]  R. Webster,et al.  Highly Pathogenic Reassortant Avian Influenza A(H5N1) Virus Clade 2.3.2.1a in Poultry, Bhutan , 2016, Emerging infectious diseases.

[80]  M. Moghadami.  A Narrative Review of Influenza: A Seasonal and Pandemic Disease , 2016, Iranian journal of medical sciences.

[81]  Lu Lu,et al.  Role for migratory wild birds in the global spread of avian influenza H5N8 , 2016, Science.

[82]  E. Fodor,et al.  Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis , 2016, Nature Reviews Microbiology.

[83]  A. Tatem,et al.  Global epidemiology of avian influenza A(H5N1) virus infection in humans, 1997 – 2015: a systematic review , 2016, The Lancet. Infectious diseases.

[84]  Burak Derkus,et al.  Applying the miniaturization technologies for biosensor design. , 2016, Biosensors & bioelectronics.

[85]  K. Ikuta,et al.  Novel Polymerase Gene Mutations for Human Adaptation in Clinical Isolates of Avian H5N1 Influenza Viruses , 2016, PLoS pathogens.

[86]  Wonyong Kim,et al.  Intersubtype Reassortments of H5N1 Highly Pathogenic Avian Influenza Viruses Isolated from Quail , 2016, PloS one.

[87]  H. Mao,et al.  Surveillance of Avian H7N9 Virus in Various Environments of Zhejiang Province, China before and after Live Poultry Markets Were Closed in 2013–2014 , 2015, PloS one.

[88]  Wei Zhang,et al.  RIG-I and TLR3 are both required for maximum interferon induction by influenza virus in human lung alveolar epithelial cells. , 2015, Virology.

[89]  Tiago J. S. Lopes,et al.  Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus , 2015, Nature Communications.

[90]  Anne M Johnson,et al.  Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study. , 2015, American journal of respiratory and critical care medicine.

[91]  J. Kwang,et al.  A Novel Humanized Antibody Neutralizes H5N1 Influenza Virus via Two Different Mechanisms , 2015, Journal of Virology.

[92]  E. Klipp,et al.  Influenza A matrix protein M1 multimerizes upon binding to lipid membranes. , 2014, Biophysical journal.

[93]  H. Klenk,et al.  PB2 Mutations D701N and S714R Promote Adaptation of an Influenza H5N1 Virus to a Mammalian Host , 2014, Journal of Virology.

[94]  Akiko Iwasaki,et al.  Innate immunity to influenza virus infection , 2014, Nature Reviews Immunology.

[95]  Zhicong Yang,et al.  Enhanced disinfection and regular closure of wet markets reduced the risk of avian influenza A virus transmission. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[96]  Ruben O. Donis,et al.  Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses , 2014, Influenza and other respiratory viruses.

[97]  K. Subbarao,et al.  H5N1 vaccines in humans. , 2013, Virus research.

[98]  K. Subbarao,et al.  Mammalian Adaptation in the PB2 Gene of Avian H5N1 Influenza Virus , 2013, Journal of Virology.

[99]  H. Hammad,et al.  Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections , 2013, Mucosal Immunology.

[100]  P. Buchy,et al.  Environment: a potential source of animal and human infection with influenza A (H5N1) virus , 2012, Influenza and other respiratory viruses.

[101]  Theo M Bestebroer,et al.  Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets , 2012, Science.

[102]  Maria Zambon,et al.  Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives. , 2012, The Lancet. Infectious diseases.

[103]  A. Osterhaus,et al.  Characterization of the Human CD8+ T Cell Response following Infection with 2009 Pandemic Influenza H1N1 Virus , 2011, Journal of Virology.

[104]  J. Chou,et al.  Influenza M2 proton channels. , 2011, Biochimica et biophysica acta.

[105]  Hualan Chen,et al.  New Avian Influenza Virus (H5N1) in Wild Birds, Qinghai, China , 2011, Emerging infectious diseases.

[106]  Helen H. Lee,et al.  Nucleic Acid Dipstick Test for Molecular Diagnosis of Pandemic H1N1 , 2010, Journal of Clinical Microbiology.

[107]  W. Barclay,et al.  Mutations in H5N1 Influenza Virus Hemagglutinin that Confer Binding to Human Tracheal Airway Epithelium , 2009, PloS one.

[108]  Michael G. Katze,et al.  A Single-Amino-Acid Substitution in a Polymerase Protein of an H5N1 Influenza Virus Is Associated with Systemic Infection and Impaired T-Cell Activation in Mice , 2009, Journal of Virology.

[109]  Jianhong Wu,et al.  Role of Positive Selection Pressure on the Evolution of H5N1 Hemagglutinin , 2009, Genom. Proteom. Bioinform..

[110]  T. Jones.  GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infection. , 2009, Current opinion in molecular therapeutics.

[111]  C. Bridges,et al.  H5N1 vaccine hits the target, but not the bull's eye. , 2007, The Lancet. Infectious diseases.

[112]  Chak Sangma,et al.  An Avian Influenza H5N1 Virus That Binds to a Human-Type Receptor , 2007, Journal of Virology.

[113]  J. Farrar,et al.  Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza , 2007, PLoS medicine.

[114]  C. Cheung,et al.  Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. , 2007, The Journal of general virology.

[115]  David E. Swayne,et al.  Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus , 2006, Nature.

[116]  Hideo Goto,et al.  Avian flu: Isolation of drug-resistant H5N1 virus , 2005, Nature.

[117]  A. Moscona.  Neuraminidase inhibitors for influenza. , 2005, The New England journal of medicine.

[118]  R. Webster,et al.  Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. , 2005, The Journal of infectious diseases.

[119]  J. Peiris,et al.  Re-emergence of fatal human influenza A subtype H5N1 disease , 2004, The Lancet.

[120]  Y. Guan,et al.  Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? , 2002, The Lancet.

[121]  M. Peiris,et al.  Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.

[122]  R. Webster,et al.  Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus , 1998, The Lancet.

[123]  H. Soleimanjahi,et al.  Development of Multiplex Reverse Transcription-Polymerase Chain Reaction for Simultaneous Detection of Influenza A, B and Adenoviruses , 2018, Iranian journal of pathology.

[124]  M. Kurokawa,et al.  T-705 (Favipiravir) suppresses tumor necrosis factor α production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug. , 2017, Acta virologica.

[125]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[126]  L. Gubareva,et al.  Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt. , 2009, Journal of infection and public health.

[127]  [Information about avian influenza]. , 2006, Tijdschrift voor diergeneeskunde.

[128]  M. Ciccozzi,et al.  Avian Influenza: Could the H5N1 Virus Be a Potential Next Threat? , 2023, Microbiology Research.